GlassScriptPhysician profile
Rochelle Bardis
NPI 1932685856
$4,324.17
in general payments reported to CMS, 2019-2025
36 companies · $1,316 in 2025
The $1,316 reported for 2025 was more than what 89% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $47.29 · 2022: $652 · 2023: $1,051 · 2024: $1,258 · 2025: $1,316.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,625.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,625.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $791.80 | 2022-2025 | |
| Pfizer INC. | $454.31 | 2022-2025 | |
| Merck Sharp & Dohme LLC | $437.99 | 2022-2024 | Verquvo |
| Amgen INC. | $332.89 | 2021-2025 | Repatha, Repatha |
| Janssen Pharmaceuticals, INC | $255.91 | 2022-2024 | Xarelto |
| Boehringer Ingelheim Pharmaceuticals, INC. | $230.89 | 2022-2025 | Jardiance |
| Esperion Therapeutics, INC. | $217.50 | 2023-2025 | Nexletol |
| Boston Scientific Corporation | $163.39 | 2023-2024 | Lux-Dx Insertable Cardiac Monitor, Watchman, Watchman Flx |
| Philips North America LLC | $142.25 | 2023-2025 | (Ck4) Mcot, Ecc Solutions |
| Sanofi-Aventis U.S. LLC | $114.17 | 2022-2024 | |
| Alnylam Pharmaceuticals INC. | $113.26 | 2023-2025 | Amvuttra, Givlaari |
| E.R. Squibb & Sons, L.L.C. | $93.07 | 2022-2025 | Camzyos |
| Kiniksa Pharmaceuticals International, Plc | $91.03 | 2024 | Arcalyst |
| Bayer Healthcare Pharmaceuticals INC. | $89.56 | 2022-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $83.04 | 2023-2025 | Lifevest |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Actelion Pharmaceuticals US, INC. | $78.68 | 2024-2025 | Uptravi, Opsumit |
| Novo Nordisk INC | $70.03 | 2024-2025 | Wegovy, Ozempic, Rybelsus |
| Astrazeneca Pharmaceuticals LP | $54.56 | 2021-2025 | Wainua, Farxiga |
| Abbott Laboratories | $44.50 | 2023 | Tendril, Gallant |
| Abiomed | $44.17 | 2023-2024 | Impella |
| Bridgebio Pharma, INC. | $43.74 | 2025 | Attruby |
| Daiichi Sankyo INC. | $42.67 | 2022-2023 | Injectafer |
| Kiniksa Pharmaceuticals, LTD. | $37.83 | 2023 | Arcalyst |
| Inspire Medical Systems, INC. | $34.74 | 2024 | Inspire |
| Regeneron Healthcare Solutions, INC. | $31.85 | 2025 | Evkeeza |
| Scpharmaceuticals INC. | $27.16 | 2024 | |
| Endotronix, INC. | $25.57 | 2025 | Cordella Pulomonary Artery Pressure Sensor |
| Impulse Dynamics (USA) INC. | $24.96 | 2022 | |
| Tactile Systems Technology INC | $24.14 | 2025 | Flexitouch Plus, Nimbl |
| Cardiva Medical, INC. | $22.99 | 2024 | Cardiva Vascade Mvp Vvcs 6-12f |
| Genzyme Corporation | $21.98 | 2022 | |
| Itamar Medical INC | $17.90 | 2021 | |
| Azurity Pharmaceuticals, INC. | $17.74 | 2023 | Edarbi |
| Cvrx, INC. | $16.95 | 2024 | Barostim Neo System |
| Ionis Pharmaceuticals, INC. | $15.69 | 2025 | Tryngolza |
| Convatec INC. | $15.26 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rochelle Bardis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.